93 related articles for article (PubMed ID: 2137405)
1. Effect of depot medroxyprogesterone acetate and testosterone oenanthate on serum lipoproteins in man.
Wallace EM; Wu FC
Contraception; 1990 Jan; 41(1):63-71. PubMed ID: 2137405
[TBL] [Abstract][Full Text] [Related]
2. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
[TBL] [Abstract][Full Text] [Related]
3. Transient reduction in serum HDL-cholesterol following medroxyprogesterone acetate and testosterone cypionate administration to healthy men.
Friedl KE; Plymate SR; Paulsen CA
Contraception; 1985 Apr; 31(4):409-20. PubMed ID: 3159547
[TBL] [Abstract][Full Text] [Related]
4. Effect of testosterone enanthate on serum lipoproteins in man.
Anderson RA; Wallace EM; Wu FC
Contraception; 1995 Aug; 52(2):115-9. PubMed ID: 8536448
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of depot-medroxyprogesterone acetate on lipoprotein metabolism.
Garza-Flores J; De la Cruz DL; Valles de Bourges V; Sanchez-Nuncio R; Martinez M; Fuziwara JL; Pérez-Palacios G
Contraception; 1991 Jul; 44(1):61-71. PubMed ID: 1832626
[TBL] [Abstract][Full Text] [Related]
6. Testosterone enanthate at a dose of 200 mg/week decreases HDL-cholesterol levels in healthy men.
Meriggiola MC; Marcovina S; Paulsen CA; Bremner WJ
Int J Androl; 1995 Oct; 18(5):237-42. PubMed ID: 8567093
[TBL] [Abstract][Full Text] [Related]
7. Serum lipids and lipoproteins during therapeutic amenorrhea induced by lynestrenol and depot-medroxyprogesterone acetate.
Huovinen K; Tikkanen MJ; Autio S; Härkönen T; Lommi L; Varonen S; Wilska ML
Acta Obstet Gynecol Scand; 1991; 70(4-5):349-54. PubMed ID: 1836088
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Disease Risk Associated With the Long-term Use of Depot Medroxyprogesterone Acetate.
Dilshad H; Yousuf RI; Shoaib MH; Jamil S; Khatoon H
Am J Med Sci; 2016 Nov; 352(5):487-492. PubMed ID: 27865296
[TBL] [Abstract][Full Text] [Related]
9. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
10. High-dose depot-medroxyprogesterone acetate (DMPA) - effects on lipid and lipoprotein metabolism.
Crona N; Enk L; Samsioe G; Silfverstolpe G; Skryten A
Eur J Obstet Gynecol Reprod Biol; 1983 Oct; 16(2):97-105. PubMed ID: 6227506
[TBL] [Abstract][Full Text] [Related]
11. Suppression of sperm function by depot medroxyprogesterone acetate and testosterone enanthate in steroid male contraception.
Wu FC; Aitken RJ
Fertil Steril; 1989 Apr; 51(4):691-8. PubMed ID: 2522398
[TBL] [Abstract][Full Text] [Related]
12. [Injectable contraceptive, DMPA, serum HDL cholesterol and heart infarct].
Kremer J; de Bruijn HW; Hindriks FR
Ned Tijdschr Geneeskd; 1981 Aug; 125(35):1418-21. PubMed ID: 6456421
[TBL] [Abstract][Full Text] [Related]
13. Effects of long-term use of testosterone enanthate. II. Effects on lipids, high and low density lipoprotein cholesterol and liver function parameters.
Tyagi A; Rajalakshmi M; Jeyaraj DA; Sharma RS; Bajaj JS
Int J Androl; 1999 Dec; 22(6):347-55. PubMed ID: 10624603
[TBL] [Abstract][Full Text] [Related]
14. Effects of estrone sulfate alone or with medroxyprogesterone acetate on serum lipoprotein levels in postmenopausal women.
Luciano AA; Miller BE; Schoenenfeld MJ; Schaser RJ;
Obstet Gynecol; 2001 Jan; 97(1):101-8. PubMed ID: 11152917
[TBL] [Abstract][Full Text] [Related]
15. Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men.
McLachlan RI; O'Donnell L; Stanton PG; Balourdos G; Frydenberg M; de Kretser DM; Robertson DM
J Clin Endocrinol Metab; 2002 Feb; 87(2):546-56. PubMed ID: 11836283
[TBL] [Abstract][Full Text] [Related]
16. Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception.
Knuth UA; Yeung CH; Nieschlag E
Fertil Steril; 1989 Jun; 51(6):1011-8. PubMed ID: 2524404
[TBL] [Abstract][Full Text] [Related]
17. Effect of depo-medroxyprogesterone acetate on coagulation factors and serum lipids in Egyptian women.
Fahmy K; Khairy M; Allam G; Gobran F; Alloush M
Contraception; 1991 Oct; 44(4):431-44. PubMed ID: 1836755
[TBL] [Abstract][Full Text] [Related]
18. Pregnancies associated with sperm concentrations below 10 million/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters.
Barfield A; Melo J; Coutinho E; Alvarez-Sanchez F; Faundes A; Brache V; Leon P; Frick J; Bartsch G; Weiske WH; Brenner P; Mishell D; Bernstein G; Ortiz A
Contraception; 1979 Aug; 20(2):121-7. PubMed ID: 487815
[TBL] [Abstract][Full Text] [Related]
19. Impact on lipoprotein profile after long-term testosterone replacement in hypogonadal men.
Berg G; Schreier L; Geloso G; Otero P; Nagelberg A; Levalle O
Horm Metab Res; 2002 Feb; 34(2):87-92. PubMed ID: 11972293
[TBL] [Abstract][Full Text] [Related]
20. The interaction of alcohol consumption and oral contraceptive use on lipids and lipoproteins.
Kruszon-Moran D; Burkman RT; Kimball AW; Bachorik PS; Gold EB
Contraception; 1988 Jan; 37(1):39-51. PubMed ID: 3365983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]